Programs

  • Program 1 [2020]

    THE ORGANIZATION IS ESTABLISHING A STANDING GLOBAL TRIAL-READY PLATFORM TO DRIVE QUALITY, EFFICIENCY, AND INNOVATION IN ALZHEIMERS CLINICAL TRIALS, SEEKING TO REDUCE CLINICAL TESTING CYCLE TIMES BY TWO YEARS AND TO ACHIEVE GREATER UNIFORMITY IN TRIAL POPULATIONS. IT IS DOING THAT BY BUILDING LARGE, WELL-CHARACTERIZED TRIAL-READY COHORTS, AND A NETWORK OF CERTIFIED HIGH-PERFORMANCE CLINICAL TRIAL SITES.
    Geographies
    Not indicated
    Dates
    Jan 1, 2020 – Dec 31, 2020
    Source
    990
    No causes provided
    No populations provided
    –
    $4.1M

  • Global Trial-Ready Platform for Alzheimer's

    THE ORGANIZATION IS ESTABLISHING A STANDING GLOBAL TRIAL-READY PLATFORM TO DRIVE QUALITY, EFFICIENCY, AND INNOVATION IN ALZHEIMER'S CLINICALTRIALS, SEEKING TO REDUCE CLINICAL TESTING CYCLE TIMES BY TWO YEARS AND TO ACHIEVE GREATER UNIFORMITY IN TRIAL POPULATIONS. IT IS DOING THAT BY BUILDING LARGE, WELL-CHARACTERIZED TRIAL-READY COHORTS, AND A NETWORK OF CERTIFIED HIGH-PERFORMANCE CLINICAL TRIAL SITES.
    Geographies
    Not indicated
    Dates
    Jan 1, 2022 – Dec 31, 2022
    Source
    990
    No causes provided
    No populations provided
    –
    $7.3M